Cwm LLC Has $32,000 Holdings in Veradigm Inc. (NASDAQ:MDRX)

Cwm LLC boosted its stake in Veradigm Inc. (NASDAQ:MDRXGet Rating) by 578.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,103 shares of the software maker’s stock after purchasing an additional 1,793 shares during the quarter. Cwm LLC’s holdings in Veradigm were worth $32,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the stock. Robeco Institutional Asset Management B.V. bought a new stake in Veradigm in the third quarter worth about $93,000. MQS Management LLC purchased a new position in Veradigm during the second quarter valued at approximately $154,000. Prelude Capital Management LLC purchased a new position in Veradigm during the second quarter valued at approximately $156,000. Ritholtz Wealth Management purchased a new position in Veradigm during the third quarter valued at approximately $158,000. Finally, Inspire Investing LLC grew its stake in Veradigm by 37.9% during the second quarter. Inspire Investing LLC now owns 14,360 shares of the software maker’s stock valued at $213,000 after acquiring an additional 3,943 shares in the last quarter. 99.76% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Veradigm

In other news, CEO Richard J. Poulton sold 10,000 shares of the company’s stock in a transaction dated Tuesday, November 15th. The shares were sold at an average price of $18.14, for a total value of $181,400.00. Following the sale, the chief executive officer now directly owns 722,517 shares of the company’s stock, valued at approximately $13,106,458.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Richard J. Poulton sold 10,000 shares of the company’s stock in a transaction dated Tuesday, November 15th. The shares were sold at an average price of $18.14, for a total value of $181,400.00. Following the sale, the chief executive officer now directly owns 722,517 shares of the company’s stock, valued at approximately $13,106,458.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Tejal Vakharia sold 8,642 shares of the stock in a transaction dated Monday, December 12th. The shares were sold at an average price of $18.42, for a total transaction of $159,185.64. Following the sale, the senior vice president now directly owns 222,604 shares in the company, valued at $4,100,365.68. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 61,776 shares of company stock valued at $1,137,271. 2.29% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Piper Sandler reaffirmed an “overweight” rating and set a $17.00 price objective on shares of Veradigm in a research note on Friday, November 4th. JPMorgan Chase & Co. lifted their target price on shares of Veradigm from $19.00 to $20.00 and gave the company an “underweight” rating in a research report on Friday, November 18th. Argus upgraded shares of Veradigm from a “hold” rating to a “buy” rating and set a $26.00 target price for the company in a research report on Wednesday, December 7th. They noted that the move was a valuation call. TheStreet upgraded shares of Veradigm from a “c+” rating to a “b-” rating in a research report on Wednesday, November 30th. Finally, StockNews.com initiated coverage on shares of Veradigm in a report on Wednesday, October 12th. They issued a “hold” rating for the company. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the company. According to MarketBeat, Veradigm presently has an average rating of “Moderate Buy” and a consensus price target of $22.67.

Veradigm Trading Up 0.7 %

NASDAQ:MDRX opened at $18.50 on Friday. The company has a fifty day moving average of $18.26 and a 200 day moving average of $16.69. Veradigm Inc. has a 52 week low of $13.59 and a 52 week high of $23.25. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.17. The firm has a market capitalization of $2.02 billion, a P/E ratio of 43.02, a P/E/G ratio of 1.60 and a beta of 1.01.

Veradigm (NASDAQ:MDRXGet Rating) last posted its quarterly earnings results on Thursday, November 3rd. The software maker reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.05. The company had revenue of $151.90 million during the quarter, compared to analyst estimates of $152.79 million. Veradigm had a net margin of 7.25% and a return on equity of 10.74%. The firm’s revenue was up 5.0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.21 EPS. On average, research analysts predict that Veradigm Inc. will post 0.68 earnings per share for the current year.

About Veradigm

(Get Rating)

Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Stories

Institutional Ownership by Quarter for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.